
Sign up to save your podcasts
Or


This week, please join authors Charles Khouri and Clément Jambon-Barbara as well as Associate Editor Kelly Chin as they discuss the article "Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260330.77255
By Greg Hundley, MD and Peder Myhre, MD, PhD4.3
3030 ratings
This week, please join authors Charles Khouri and Clément Jambon-Barbara as well as Associate Editor Kelly Chin as they discuss the article "Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260330.77255

134 Listeners

321 Listeners

504 Listeners

167 Listeners

906 Listeners

298 Listeners

3,374 Listeners

138 Listeners

1,150 Listeners

194 Listeners

94 Listeners

518 Listeners

367 Listeners

437 Listeners

375 Listeners